Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
74.97
+0.11 (0.15%)
Dec 5, 2025, 4:00 PM EST - Market closed
Hologic Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Hologic stock have an average target of 79.64, with a low estimate of 70 and a high estimate of 90. The average target predicts an increase of 6.23% from the current stock price of 74.97.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Hologic stock from 15 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 4 | 5 | 5 | 2 | 2 | 2 |
| Hold | 8 | 7 | 7 | 11 | 11 | 11 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 14 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $69 → $76 | Hold | Maintains | $69 → $76 | +1.37% | Nov 11, 2025 |
| Mizuho | Mizuho | Buy → Hold Downgrades $70 → $78 | Buy → Hold | Downgrades | $70 → $78 | +4.04% | Oct 23, 2025 |
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 22, 2025 |
| Stephens & Co. | Stephens & Co. | Buy → Hold Downgrades $78 → $76 | Buy → Hold | Downgrades | $78 → $76 | +1.37% | Oct 22, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $78 | Buy → Hold | Downgrades | $78 | +4.04% | Oct 22, 2025 |
Financial Forecast
Revenue This Year
4.38B
from 4.10B
Increased by 6.69%
Revenue Next Year
4.63B
from 4.38B
Increased by 5.74%
EPS This Year
4.64
from 2.49
Increased by 86.42%
EPS Next Year
5.11
from 4.64
Increased by 10.02%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 4.5B | 4.8B | ||
| Avg | 4.4B | 4.6B | ||
| Low | 4.1B | 4.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 10.6% | 9.8% | ||
| Avg | 6.7% | 5.7% | ||
| Low | 0.9% | 0.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 4.88 | 5.44 | ||
| Avg | 4.64 | 5.11 | ||
| Low | 4.31 | 4.74 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 96.1% | 17.2% | ||
| Avg | 86.4% | 10.0% | ||
| Low | 73.2% | 2.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.